|
1
|
Ferri C, Antonelli A, Mascia MT,
Sebastiani M, Fallahi P, Ferrari D, Pileri SA and Zignego AL:
HCV-related autoimmune and neoplastic disorders: The HCV syndrome.
Dig Liver Dis. 39 Suppl 1:13–21. 2007. View Article : Google Scholar
|
|
2
|
Dammacco F and Sansonno D: Antibodies to
hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp
Immunol. 87:352–356. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Neumann AU, Lam NP, Dahari H, Gretch DR,
Wiley TE, Layden TJ and Perelson AS: Hepatitis C viral dynamics in
vivo and the antiviral efficacy of interferon-a therapy. Science.
282:103–107. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dammacco F, Sansonno D, Piccoli C, Tucci
FA and Racanelli V: The cryoglobulins: An overview. Eur J Clin
Invest. 31:628–638. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
lannuzzella F, Vaglio A and Garini G:
Management of hepatitis C virus-related mixed cryoglobulinemia. Am
J Med. 123:400–408. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao LJ, Chen F, Li JG, Yin R, Zhang XH,
Huang SM and Liu F: Hepatitis C virus-related mixed
cryoglobulinemic endocapillary proliferative glomerulonephritis and
B-cell non-Hodgkin lymphoma: A case report and literature review.
Eur Rev Med Pharmacol Sci. 19:3050–3055. 2015.PubMed/NCBI
|
|
7
|
Tarantino A, De Vecchi A, Montagnino G,
Imbasciati E, Mihatsch MJ, Zollinger HU, Di Belgiojoso GB, Busnach
G and Ponticeli C: Renal disease in essential mixed
cryoglobulinaemia. Long-term follow-up of 44 patients. Q J Med.
50:1–30. 1981.PubMed/NCBI
|
|
8
|
Daghestani L and Pomeroy C: Renal
manifestations of hepatitis C infection. Am J Med. 106:347–354.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ferri C, Sebastiani M, Giuggioli D,
Cazzato M, Longombardo G, Antonelli A, Puccini R, Michelassi C and
Zignego AL: Mixed cryoglobulinemia: Demographic, clinical and
serologic features and survival in 231 patients. Semin Arthritis
Rheum. 33:355–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ozkok A and Yildiz A: Hepatitis C virus
associated glomerulopathies. World J Gastroenterol. 20:7544–7554.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Misiani R, Bellavita P, Fenili D, Borelli
G, Marchesi D, Massazza M, Vendramin G, Comotti B, Tanzi E,
Scudeller G, et al: Hepatitis C virus infection in patients with
essential mixed cryoglobulinemia. Ann Intern Med. 117:573–577.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tarantino A, Campise M, Banfi G,
Conflalonieri R, Bucci A, Montonli A, Cloasanti G, Damilano I,
D'Amico G, Minetti L, et al: Long-term predictors of survival in
essential mixed cryoglobulinemic glomerulonephritis. Kidney Int.
47:618–623. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhattarai M, Woytowitz DV, Kaldash H,
Bastacky S, Chen SS, Johnston JR and Bernardo JF: Recurrent mixed
cryoglobulinemia (MCS): A case report and literature review. R I
Med J (2013). 98:33–37. 2015.PubMed/NCBI
|
|
14
|
De Vita S and Quartuccio L: Treatment of
rheumatoid arthritis with rituximab: An update and possible
indications. Autoimmun Rev. 5:443–448. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Grillo-López AJ, Hedrick E, Rashford M and
Benyunes M: Rituximab: Ongoing and future clinical development.
Semin Oncol. 29 1 Suppl 2:1–112. 2002. View Article : Google Scholar
|
|
16
|
Patel DD: B cell-ablative therapy for the
treatment of autoimmune diseases. Arthritis Rheum. 46:1984–1985.
2002. View Article : Google Scholar : PubMed/NCBI
|
